Daniel Melman

Associate

Weil, Gotshal & Manges LLP

Current

Current

Yeda Research and Development Company Israel Bio-Engineering Project v. Amgen, Inc. Weil Gotshal obtained summary judgment in the trial court, eliminating a critical challenge to client Yeda’s ownership claims to the patent covering Amgen’s blockbuster biotech drug Enbrel®. On appeal, Weil Gotshal’s appellate team secured the Federal Circuit’s affirmance. more

Current

Yeda Research and Development Company Yeda Research v. ImClone Systems, et al. In a trial victory that Fortune magazine called “unequivocal,” Weil Gotshal obtained an order directing that the named inventors on the patent protecting ImClone’s billion-dollar cancer drug, Erbitux™, be replaced with Yeda’s scientists. more

St John's University

J.D.

2001

Polytechnic University

B.S.

1995

Publication